These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 30371053)

  • 1. Quantifying Co-Oligomer Formation by α-Synuclein.
    Iljina M; Dear AJ; Garcia GA; De S; Tosatto L; Flagmeier P; Whiten DR; Michaels TCT; Frenkel D; Dobson CM; Knowles TPJ; Klenerman D
    ACS Nano; 2018 Nov; 12(11):10855-10866. PubMed ID: 30371053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. α-synuclein-assisted oligomerization of β-amyloid (1-42).
    Chau E; Kim JR
    Arch Biochem Biophys; 2022 Mar; 717():109120. PubMed ID: 35041853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crucial role of protein oligomerization in the pathogenesis of Alzheimer's and Parkinson's diseases.
    Choi ML; Gandhi S
    FEBS J; 2018 Oct; 285(19):3631-3644. PubMed ID: 29924502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation and characterization of neurotoxic tau oligomers.
    Lasagna-Reeves CA; Castillo-Carranza DL; Guerrero-Muoz MJ; Jackson GR; Kayed R
    Biochemistry; 2010 Nov; 49(47):10039-41. PubMed ID: 21047142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Amyloid Switch Triggered by Early Heterotypic Oligomerization of Intrinsically Disordered α-Synuclein and Tau.
    Bhasne K; Sebastian S; Jain N; Mukhopadhyay S
    J Mol Biol; 2018 Aug; 430(16):2508-2520. PubMed ID: 29704492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level.
    Nübling G; Bader B; Levin J; Hildebrandt J; Kretzschmar H; Giese A
    Mol Neurodegener; 2012 Jul; 7():35. PubMed ID: 22824345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
    Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
    Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shedding light on aberrant interactions - a review of modern tools for studying protein aggregates.
    Kundel F; Tosatto L; Whiten DR; Wirthensohn DC; Horrocks MH; Klenerman D
    FEBS J; 2018 Oct; 285(19):3604-3630. PubMed ID: 29453901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative analysis of co-oligomer formation by amyloid-beta peptide isoforms.
    Iljina M; Garcia GA; Dear AJ; Flint J; Narayan P; Michaels TC; Dobson CM; Frenkel D; Knowles TP; Klenerman D
    Sci Rep; 2016 Jun; 6():28658. PubMed ID: 27346247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-seeding effects of amyloid β-protein and α-synuclein.
    Ono K; Takahashi R; Ikeda T; Yamada M
    J Neurochem; 2012 Sep; 122(5):883-90. PubMed ID: 22734715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of antiparkinsonian agents on β-amyloid and α-synuclein oligomer formation in vitro.
    Ono K; Takasaki J; Takahashi R; Ikeda T; Yamada M
    J Neurosci Res; 2013 Oct; 91(10):1371-81. PubMed ID: 23913715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties.
    Planchard MS; Exley SE; Morgan SE; Rangachari V
    Protein Sci; 2014 Oct; 23(10):1369-79. PubMed ID: 25044276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions.
    Cieplak AS
    PLoS One; 2017; 12(9):e0180905. PubMed ID: 28922400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the Molecular Mechanisms of Alzheimer's and Parkinson's Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology.
    Coskuner-Weber O; Uversky VN
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of α-synuclein oligomers with lipid membranes.
    Musteikytė G; Jayaram AK; Xu CK; Vendruscolo M; Krainer G; Knowles TPJ
    Biochim Biophys Acta Biomembr; 2021 Apr; 1863(4):183536. PubMed ID: 33373595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the Structures of Amyloid Oligomers with Macrocyclic β-Hairpin Peptides: Insights into Alzheimer's Disease and Other Amyloid Diseases.
    Kreutzer AG; Nowick JS
    Acc Chem Res; 2018 Mar; 51(3):706-718. PubMed ID: 29508987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structures of the intrinsically disordered Aβ, tau and α-synuclein proteins in aqueous solution from computer simulations.
    Nguyen PH; Derreumaux P
    Biophys Chem; 2020 Sep; 264():106421. PubMed ID: 32623047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct Correlation Between Ligand-Induced α-Synuclein Oligomers and Amyloid-like Fibril Growth.
    Nors Perdersen M; Foderà V; Horvath I; van Maarschalkerweerd A; Nørgaard Toft K; Weise C; Almqvist F; Wolf-Watz M; Wittung-Stafshede P; Vestergaard B
    Sci Rep; 2015 May; 5():10422. PubMed ID: 26020724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. αS Oligomers Generated from Interactions with a Polyunsaturated Fatty Acid and a Dopamine Metabolite Differentially Interact with Aβ to Enhance Neurotoxicity.
    Dhakal S; Saha J; Wyant CE; Rangachari V
    ACS Chem Neurosci; 2021 Nov; 12(21):4153-4161. PubMed ID: 34665617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.